Amyloid burden in the hippocampus and default mode network: Relationships with gray matter volume and cognitive performance in mild stage Alzheimer disease

Medicine (United States)

Volumn 94, Issue 16, 2015, Pages

  Chang, Ya Ting ^a   Huang, Chi Wei ^a   Chang, Yen Hsiang ^a   Chen, Nai Ching ^a   Lin, Kun Ju ^a   Yan, Tzu Chen ^a   Chang, Wen Neng ^a   Chen, Sz Fan ^a,b   Lui, Chun Chung ^b   Lin, Pin Hsuan ^c   Chang, Chiung Chih ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c Shu Zen College of Medicine and Management   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANTERIOR CINGULATE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CLINICAL ARTICLE; CLINICAL DEMENTIA RATING; COGNITIVE DEFECT; DEFAULT MODE NETWORK; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; MALE; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PRECUNEUS; PRIORITY JOURNAL; TEMPORAL LOBE; WORD RECOGNITION; DIAGNOSTIC USE; METABOLISM; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PATHOLOGY; PROSPECTIVE STUDY; VERY ELDERLY;

AMYLOID; ANILINE DERIVATIVE; ETHYLENE GLYCOL DERIVATIVE; FLORBETAPIR; FLUORINE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID; ANILINE COMPOUNDS; ETHYLENE GLYCOLS; FEMALE; FLUORINE RADIOISOTOPES; GRAY MATTER; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES;

EID: 84929660584     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000763     Document Type: Article

References (38)

1. Dubois B, Feldman HH, Jacova C, et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. Lancet Neurol. 2014;13:614-629.
2. Weiner MW, Veitch DP, Aisen PS, et al. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement. 2012;8:S1-68.
3. Greicius MD, Srivastava G, Reiss AL, et al. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A. 2004;101:4637-4642.
4. Chetelat G, Villemagne VL, Bourgeat P, et al. Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Ann Neurol. 2010;67:317-324.
5. Oh H, Habeck C, Madison C, et al. Covarying alterations in Abeta deposition, glucose metabolism, and gray matter volume in cognitively normal elderly. Hum Brain Mapp. 2014;35:297-308.
6. Clark CM, Pontecorvo MJ, Beach TG, et al. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-beta plaques: a prospective cohort study. Lancet Neurol. 2012;11:669-678.
7. Johnson KA, Minoshima S, Bohnen NI, et al. Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association. Alzheimers Dement. 2013;9:e-1-16.
8. Rosenberg PB, Wong DF, Edell SL, et al. Cognition and amyloid load in Alzheimer disease imaged with florbetapir F 18(AV-45) positron emission tomography. Am J Geriatr Psychiatry. 2013;21:272-278.
9. Fazio F, Perani D. Importance of partial-volume correction in brain PET studies. J Nucl Med. 2000;41:1849-1850.
10. Ashburner J, Friston KJ. Voxel-based morphometry-the methods. Neuroimage. 2000;11:805-821.
11. Greenberg DL, Messer DF, Payne ME, et al. Aging, gender, and the elderly adult brain: an examination of analytical strategies. Neurobiol Aging. 2008;29:290-302.
12. Voevodskaya O, Simmons A, Nordenskjold R, et al. The effects of intracranial volume adjustment approaches on multiple regional MRI volumes in healthy aging and Alzheimer's disease. Front Aging Neurosci. 2014;6:264.
13. Karow DS, McEvoy LK, Fennema-Notestine C, et al. Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease. Radiology. 2010;256:932-942.
14. Tsai RM, Leong JK, Dutt S, et al. The Chinese verbal learning test specifically assesses hippocampal state. Am J Alzheimers Dis Other Demen. 2014pii: 1533317514552667.
15. Teng E, Chow N, Hwang KS, et al. Low Plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohort. Dement Geriatr Cogn Disord. 2014;39:154-166.
16. Kramer JH, Schuff N, Reed BR, et al. Hippocampal volume and retention in Alzheimer's disease. J Int Neuropsychol Soc. 2004;10:639-643.
17. Li Y, Rinne JO, Mosconi L, et al. Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2008;35:2169-2181.
18. Mosconi L, Rinne JO, Tsui WH, et al. Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of lateonset Alzheimer's. Proc Natl Acad Sci U S A. 2010;107:5949-5954.
19. Jack CR Jr, Wiste HJ, Lesnick TG, et al. Brain beta-amyloid load approaches a plateau. Neurology. 2013;80:890-896.
20. Chu LW, Chiu KC, Hui SL, et al. The reliability and validity of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADASCog) among the elderly Chinese in Hong Kong. Ann Acad Med Singapore. 2000;29:474-485.
21. Huang CW, Chang WN, Lui CC, et al. Impacts of hyperhomocysteinemia and white matter hyper-intensity in Alzheimer's disease patients with normal creatinine: an MRI-based study with longitudinal follow-up. Curr Alzheimer Res. 2010;7:527-533.
22. Huang CW, Chang WN, Huang SH, et al. Impact of homocysteine on cortical perfusion and cognitive decline in mild Alzheimer's dementia. Eur J Neurol. 2013;20:1191-1197.
23. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:263-269.
24. Morris JC. The clinical dementia rating (CDR): current version and scoring rules. Neurology. 1993;43:2412-2414.
25. Huang KL, Lin KJ, Hsiao IT, et al. Regional amyloid deposition in amnestic mild cognitive impairment and Alzheimer's disease evaluated by [18F]AV-45 positron emission tomography in Chinese population. PLoS One. 2013;8:e58974.
26. Rosen WG, Terry RD, Fuld PA, et al. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol. 1980;7:486-488.
27. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15:273-289.
28. Folstein MF, Folstein SE, McHugh PR. ''Mini-mental state''. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
29. Braak H, Braak E. Evolution of neuronal changes in the course of Alzheimer's disease. J Neural Transm Suppl. 1998;53:127-140.
30. Clark CM, Schneider JA, Bedell BJ, et al. Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA. 2011;305:275-283.
31. Vogt BA, Finch DM, Olson CR. Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cereb Cortex. 1992;2:435-443.
32. Sperling RA, Johnson KA, Doraiswamy PM, et al. Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals. Neurobiol Aging. 2013;34:822-831.
33. Sheline YI, Raichle ME, Snyder AZ, et al. Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly. Biol Psychiatry. 2010;67:584-587.
34. Jack CR Jr, Lowe VJ, Weigand SD, et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain. 2009;132:1355-1365.
35. Bourgeat P, Chetelat G, Villemagne VL, et al. Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia. Neurology. 2010;74:121-127.
36. Spreng RN, Mar RA, Kim AS. The common neural basis of autobiographical memory, prospection, navigation, theory of mind, and the default mode: a quantitative meta-analysis. J Cogn Neurosci. 2009;21:489-510.
37. Wolk DA, Dickerson BC. Fractionating verbal episodic memory in Alzheimer's disease. Neuroimage. 2011;54:1530-1539.
38. Golomb J, de Leon MJ, Kluger A, et al. Hippocampal atrophy in normal aging. An association with recent memory impairment. Arch Neurol. 1993;50:967-973.